ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BYOT Byotrol Plc

0.125
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.125 0.05 0.20 0.125 0.125 0.125 13,747 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.59M -1.69M -0.0037 -0.32 544.67k

Byotrol PLC Director Dealing (7465Y)

24/08/2018 7:00am

UK Regulatory


Byotrol (LSE:BYOT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Byotrol Charts.

TIDMBYOT

RNS Number : 7465Y

Byotrol PLC

24 August 2018

24 August 2018

Byotrol plc

("Byotrol", the "Company" or the "Group")

Director Dealing

Byotrol plc, the AIM listed anti-microbial technology company, is pleased to announce that on 23 August 2018, John Langlands, Non-Executive Chairman of the Company purchased 500,000 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 3.70p per Ordinary Share (the "Purchase").

Following the Purchase, Mr. Langlands has an interest in 4,600,000 Ordinary Shares representing approximately 1.07 per cent. of the total voting rights of the Company.

Enquiries:

Enquiries:

   David Traynor - Chief Executive, Byotrol plc                                      01925 742 000 

David Paton - Investor Relations 07714 190 474

finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne- Corporate Finance

Tim Redfern/Richard Chambers - Corporate Broking

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 
  1.   Details of the person discharging managerial 
        responsibilities / person closely associated 
----  --------------------------------------------------------------- 
 a)    Name                             John Langlands 
----  -------------------------------  ------------------------------ 
  2.   Reason for the Notification 
----  --------------------------------------------------------------- 
 a)    Position/status                  Non-Executive Chairman 
----  -------------------------------  ------------------------------ 
 b)    Initial notification/Amendment   Initial 
----  -------------------------------  ------------------------------ 
 3.    Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  --------------------------------------------------------------- 
 a)    Name                             Byotrol Plc 
----  -------------------------------  ------------------------------ 
 b)    LEI                              213800AJMTSTIPA59A34 
----  -------------------------------  ------------------------------ 
 4.    Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  --------------------------------------------------------------- 
 a)    Description of                   ordinary shares of 0.25p each 
        the Financial 
        instrument, type 
        of instrument 
---- 
       Identification                   GB00B0999995 
        code 
----  -------------------------------  ------------------------------ 
 b)    Nature of the                    Purchase of Ordinary Shares 
        transaction 
----  -------------------------------  ------------------------------ 
 c)    Price(s) and                     Volume - 500,000 
        volume(s)                        Price - 3.70 pence 
----  -------------------------------  ------------------------------ 
 d)    Aggregated information:          See 4c) above 
----  -------------------------------  ------------------------------ 
 e)    Date of the transaction          23 August 2018 
----  -------------------------------  ------------------------------ 
 f)    Place of the                     London Stock Exchange, AIM 
        transaction                      Market (XLON) 
----  -------------------------------  ------------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGMGZRVFFGRZM

(END) Dow Jones Newswires

August 24, 2018 02:00 ET (06:00 GMT)

1 Year Byotrol Chart

1 Year Byotrol Chart

1 Month Byotrol Chart

1 Month Byotrol Chart

Your Recent History

Delayed Upgrade Clock